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BACKGROUND & OBJECTIVE
Cardiovascular disease (CVD) accounts for significant morbidity and 
mortality in patients with chronic kidney disease (CKD). Besides the 
higher  prevalence  of  traditional  risk  factors,  several  uremia-related 
factors may play a role in accelerated atherosclerosis, such as elevated 
levels of lipoprotein (a) (Lp(a)).  Lp(a)consists of an LDL-like particle 
and the specific apolipoprotein(a) (apo(a)), which is covalently bound 
to  the  apoB of  the  LDL  like  particle.  The  effect  of  maintenance 
hemodialysis  (MHD)  on  Lp(a)  levels  is  not  well  understood.  The 
present work was carried out to study the Effect  of a single Dialysis 
session on plasma Lp(a) levels in End Stage Renal Disease (ESRD) 
patients on maintenance hemodialysis. Hourly concentrations of Lp(a) 
in plasma were measured as well. 
PATIENTS & METHODS
27  ESRD  patients  on  MHD  were  assigned  from  Nephrology  unit, 
SVIMS, Tirupati (A.P). Exclusion criteria include smoking and active 
infection.  The  patients  were  under  HD  since  three  years.  The  HD 
program consisted of four hour dialysis sessions, three times a week. 
Dialysis  was  done  with  polysulfone  membrane  using  bicarbonate 
dialysate  with  flow  rates  of  500ml/min  and  200-250  ml/min 
respectively  for  dialysate and blood. Anticoagulation was done with 
2000  IU  of  heparin  at  the  start  of  dialysis  followed  by  continuous 
administration of 500-1000 IU per hour. 
Sampling & Analysis
Pre HD, hourly and post HD blood samples were collected from the 
arterial end of the dialyzer. Plasma was obtained by centrifugation at 
3000  rpm  for  15  minutes.  Separated  plasma  was  either  analyzed 
immediately or stored at -800C for further analysis. Plasma Lp(a) levels 
were  measured  by  standard  methods  using  commercial  kits  on 
Beckman  CX9  auto  analyzer.  Values  obtained  were  corrected  for 
hemoconcentration.  The  data  were  presented  as  mean  ±  SEM. 
Statistical significance of the changes was obtained by using analysis of 
variance  for  repeated  measures  under  generalized  linear  model. 
Statistical  significance  was  established  at  a  p  value  of  .05  or  less. 
Statistical analysis was done using SPSS for windows version 16.0.
RESULTS
Results of analysis of variance for repeated measures after correction 
for hemoconcentration where necessary revealed a decrease in Lp(a) 
(p=0.022)  and  triglycerides  (p=0.001)  levels  and  no  change  in 
cholesterol (p=0.48) levels. Hourly  plasma  concentrations  of  Lp(a) 
before and after correcting for hemoconcentration were presented 
in Table:1.
DISCUSSION
High  Lp(a)  predicts  risk of  early atherosclerosis  similar  to  high 
LDL, but in advanced atherosclerosis, Lp(a) is an independent risk 
factor not dependent on LDL. Apo (a) contains domains that are 
very  similar  to  plasminogen  (PLG).  Lp(a)  accumulates  in  the 
vessel  wall  and  inhibits  binding  of  PLG  to  the  cell  surface, 
reducing  plasmin  generation  which  increases  clotting.  This 
inhibition of PLG by Lp(a) also promotes proliferation of smooth 
muscle  cells.  These  features  of  Lp(a)  generate  clots  and 
atherosclerosis.  In addition, because of LDL  cholesterol content, 
Lp-a contributes to atherosclerosis.
Elevated Lp(a) in HD patients has been reported earlier but its role 
in the development of vascular complications has not yet totally 
proven. Rather, there is controversy concerning the effect of HD 
on plasma levels  of  Lp(a).  Dialysis  membrane  and  heparin  can 
influence  lipid  parameters.  However,  there  are  limited  and 
debatable  data  concerning  lipid  alterations  during  a  single 
hemodialysis  session.  Moreover,  the  role  of  hemoconcentration 
after  every  hemodialysis  session  confuses  the  real  effect  of  the 
heparin on lipid profile.
 
In our study we found no change in plasma  Lp(a) levels as such 
after completion of HD. However significant  (p=0.022) decrease 
was observed after correcting for hemoconcentration.
Our  findings  of  decrease  in  plasma  Lp(a)  is  answered  by  the 
clearing  effect  of  heparin  on  lipids  like  HDL  and  LDL 
lipoproteins. Administration of heparin during HD had pronounced 
clearing effect for Lp(a).  Although studies show an association of 
Lp(a) and  CVD, Lp(a) cannot yet be regarded as a conventional 
risk  factor  for  CVD.  Association  of  Lp(a)  and  cardiovascular 
disease in HD patients is rather complicated, that warrant further 
research. 
CONCLUSION
Single HD session lowers  Lp(a) levels which might be due to the 
administration  of  heparin  producing  clearing  effect  on  plasma 
Lp(a) during dialysis. Furthermore, decrease in Lp(a) levels may 
have a beneficial effect on cardiovascular morbidity and mortality
Table:1: Hourly concentrations of Lp(a) in plasma of HD patients
Pre HD 1 hour 2 hour 3 hour Post HD Change (p value)
Lp(a) - mg/dL 21.2 ±2.7 22.3 ±2.9 22.1 ±3.06 22.1 ±2.9 20.6 ±2.7 → (0.14)
Lp(a) -  (mg/g Albumin)
corrected for hemoconcentration
7.41±0.9 7.89±1.0 8.30±1.1 7.81±0.6 7.0±0.9 ↓ (0.02)
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